Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.81
-0.71 (-0.30%)
AAPL  273.87
+0.47 (0.17%)
AMD  215.44
+0.45 (0.21%)
BAC  55.41
-0.76 (-1.34%)
GOOG  313.96
-1.00 (-0.32%)
META  658.76
-4.53 (-0.68%)
MSFT  486.76
-0.94 (-0.19%)
NVDA  187.66
-2.88 (-1.51%)
ORCL  195.51
-2.48 (-1.25%)
TSLA  462.57
-12.62 (-2.65%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.